The PE Ratio as of December 2024 (TTM) for Biostage, Inc. (BSTG) is -6.20

According to Biostage, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.20. This represents a change of 10.54% compared to the average of -5.61 of the last 4 quarters.

Biostage, Inc. (BSTG) Historical PE Ratio (quarterly & annually)

How has BSTG PE Ratio performed in the past?

The mean historical PE Ratio of Biostage, Inc. over the last ten years is -1.90. The current -6.20 PE Ratio has changed 32.48% with respect to the historical average. Over the past ten years (40 quarters), BSTG's PE Ratio was at its highest in in the December 2020 quarter at 0. The PE Ratio was at its lowest in in the September 2022 quarter at -19.98.

Biostage, Inc. (BSTG) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Biostage, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biostage, Inc. (BSTG) Average PE Ratio

How has BSTG PE Ratio performed in the past?

The current PE Ratio of Biostage, Inc. (BSTG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Biostage, Inc. (BSTG) PE Ratio vs. Peers

How is BSTG’s PE Ratio compared to its peers?

Biostage, Inc.’s PE Ratio is less than Biotron Limited (-4.46), less than Bioasis Technologies Inc. (0), greater than Covalon Technologies Ltd. (-98.57), greater than Mosaic ImmunoEngineering Inc. (-16.17), less than Ceapro Inc. (-2.83), less than Cellectis S.A. (-1.62), greater than SanBio Company Limited (-22.75), less than Alterity Therapeutics Limited (-1.52), less than Amplia Therapeutics Limited (-3.70), less than Adynxx, Inc. (0), greater than Nxera Pharma Co., Ltd. (-24.76), less than Antibe Therapeutics Inc. (-1.04), less than Awakn Life Sciences Corp. (-1.27), less than Tryp Therapeutics Inc. (-1.65), less than America Great Health (-4.85), less than Resverlogix Corp. (-1.22), less than Small Pharma Inc. (-2.27),

Build a custom stock screener for Biostage, Inc. (BSTG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biostage, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biostage, Inc. (BSTG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biostage, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.